377220 — From Bio Co Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩52bn
- KR₩65bn
- KR₩67bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -21,025 | -7,813 | 11,282 | 1,318 | -11,609 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 27,186 | 29,403 | 496 | 490 | -3,422 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1,305 | -6,933 | -14,025 | -4,974 | -7,460 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 5,679 | 15,609 | -1,175 | -2,023 | -20,845 |
Capital Expenditures | -2,284 | -6,630 | -11,173 | -15,184 | -16,696 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -2,343 | -2,137 | -30,912 | 10,300 | 24,025 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -4,626 | -8,768 | -42,086 | -4,884 | 7,328 |
Financing Cash Flow Items | — | — | — | 980 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 995 | -3,040 | 43,826 | 594 | 18,150 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2,045 | 3,802 | 565 | -6,313 | 4,631 |